Cost-effectiveness analysis of the prevention of mother-to-child transmission of HIV

被引:1
|
作者
Qu, Shui-ling [1 ,2 ]
Wang, Ai-ling [2 ]
Yin, Hong-mei [1 ]
Deng, Jin-qi [1 ]
Wang, Xiao-yan [2 ]
Yang, Ye-huan [2 ]
Pan, Xiao-ping [2 ]
Zhang, Tong [3 ]
机构
[1] Chinese Ctr Dis Control & Prevent, 155 Changbai Rd, Beijing 102206, Peoples R China
[2] Chinese Ctr Dis Control & Prevent, Natl Ctr Women & Childrens Hlth, 12 Dahuisi Rd, Beijing 100081, Peoples R China
[3] Capital Inst Pediat, 2 Yabao Rd, Beijing 100020, Peoples R China
关键词
Cost-effectiveness; PMTCT; HIV; Benefit-cost ratio; Individual cost; HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; MORTALITY; SYPHILIS; FAILURE; COHORT;
D O I
10.1186/s40249-022-00983-z
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background The number of HIV-positive pregnant women accounted for about 10% of China's total over the past few years in Liangshan Prefecture, Sichuan province in China. Although cost-effectiveness of the PMTCT of HIV have been evaluated in other previous studies, no specific study has been conducted in Liangshan prefecture, nor has the expenses paid individually by HIV-positive pregnant women been included. The purpose of this study was to evaluate both the short-term and long-term cost-effectiveness of PMTCT of HIV in Liangshan Prefecture from the social perspective. Methods From December 2018 to January 2019, individual expenses and the other costs were collected: individual expenses of 133 recruited HIV-positive pregnant women registered in the National Information System of Prevention of Mother-to-Child Transmission of HIV, Syphilis, and HBV, and the other costs from local maternal and child healthcare hospitals, Centers for Disease Control and Prevention, and general hospitals. The costs, the number of pediatric infections averted from being HIV infected were analyzed. And, Life years gained by pediatric infections averted were calculated by using a life table. Besides, Direct benefit was calculated through a Markov mode. Furthermore, One-way sensitivity analysis was conducted for key variables affecting the benefit-cost ratio. Results The estimated number of pediatric infections averted was 164.The total cost was USD 114.1 million, including direct medical costs, direct non-medical costs, and indirect costs, which were USD 54.2 million, USD 53.4 million, and USD 6.5 million, respectively. 630.6 person-years discounted to 2017 were gained at a 3% annual rate, and cost per life year gained was USD 1809.50. Direct benefits were USD 198.4 million, indirect benefits USD 82.5 million, and the benefit-cost ratio was 1.5. The sensitivity analysis showed that if PMTCT costs hypothetically ranged from USD 85.6 million to USD 142.6 million, benefit-cost ratio would vary from 1.0 to 2.3. Conclusions PMTCT of HIV in Liangshan Prefecture was very cost-effective. It was a great economic burden of PMTCT on HIV-positive pregnant women and their families to take individual expenses. Therefore, it could be suggested that individual expenses should be covered as much as possible by different types of financing.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of the prevention of mother-to-child transmission of HIV
    Shui-ling Qu
    Ai-ling Wang
    Hong-mei Yin
    Jin-qi Deng
    Xiao-yan Wang
    Ye-huan Yang
    Xiao-ping Pan
    Tong Zhang
    [J]. Infectious Diseases of Poverty, 11
  • [2] Cost-effectiveness of prevention of mother-to-child transmission programs
    Coovadia, Hoosen M.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S21 - S21
  • [3] Cost-effectiveness of Prevention of Mother-to-Child Transmission Programs
    Coovadia, Hoosen M.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 26 : S21 - S21
  • [4] The cost-effectiveness of preventing mother-to-child transmission of HIV in China
    Zhang, H
    Zaric, GS
    [J]. VALUE IN HEALTH, 2005, 8 (03) : 313 - 313
  • [5] Cost-effectiveness and cost-benefit in the prevention of mother-to-child transmission of HIV in developing countries
    Newell, ML
    Dabis, F
    Tolley, K
    Whynes, D
    [J]. AIDS, 1998, 12 (13) : 1571 - 1580
  • [6] Comparative cost-effectiveness of Option BR for prevention of mother-to-child transmission of HIV in Malawi
    Tweya, Hannock
    Keiser, Olivia
    Haas, Andreas D.
    Tenthani, Lyson
    Phiri, Sam
    Egger, Matthias
    Estill, Janne
    [J]. AIDS, 2016, 30 (06) : 953 - 961
  • [7] Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis
    Tchuem, Cynthia Raissa Tamandjou
    Andersson, Monique Ingrid
    Wiysonge, Charles Shey
    Mufenda, Josef
    Preiser, Wolfgang
    Cleary, Susan
    [J]. VACCINE, 2021, 39 (23) : 3141 - 3151
  • [8] Prevention of Mother-To-Child Transmission of HIV: Cost-Effectiveness of Antiretroviral Regimens and Feeding Options in Rwanda
    Binagwaho, Agnes
    Pegurri, Elisabetta
    Drobac, Peter C.
    Mugwaneza, Placidie
    Stulac, Sara N.
    Wagner, Claire M.
    Karema, Corine
    Tsague, Landry
    [J]. PLOS ONE, 2013, 8 (02):
  • [9] Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda
    Kuznik, Andreas
    Lamorde, Mohammed
    Hermans, Sabine
    Castelnuovo, Barbara
    Auerbach, Brandon
    Semeere, Aggrey
    Sempa, Joseph
    Ssennono, Mark
    Ssewankambo, Fred
    Manabe, Yukari C.
    [J]. BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2012, 90 (08) : 595 - 603
  • [10] Prevention of mother-to-child transmission of HIV-1 infection: alternative strategies and their cost-effectiveness
    Ratcliffe, J
    Ades, AE
    Gibb, D
    Sculpher, MJ
    Briggs, AH
    [J]. AIDS, 1998, 12 (11) : 1381 - 1388